Georgia Life Sciences Promotes Stacey Bowlin to Executive Vice President

Georgia Life Sciences is pleased to announce the promotion of Stacey Bowlin to Executive Vice President.

Since joining Georgia Life Sciences in 2024, Stacey has played a central role in advancing the organization's strategic visibility, industry partnerships, membership growth, and statewide engagement. Her leadership has helped strengthen Georgia Life Sciences' position as a leading voice for Georgia's biotechnology, pharmaceutical, medical device, diagnostics, and digital health sectors.

"Stacey has made an extraordinary impact on Georgia Life Sciences in a very short period of time," said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. "She successfully led our transformation from Georgia Bio to Georgia Life Sciences, helping modernize our brand and better reflect the full breadth of Georgia's life sciences industry. She has also strengthened our member recruitment and retention strategy, deepened engagement across the ecosystem, and brought a level of operational discipline that has helped position the organization for continued growth. I am thrilled to recognize Stacey's leadership and contributions with this well-deserved promotion to Executive Vice President."

In her expanded role, Stacey will continue to lead key areas of organizational strategy, operational execution, stakeholder engagement, and long-term growth. She will work closely with the CEO to support financial and organizational performance, oversee key initiatives, and help translate Georgia Life Sciences' long-term vision into actionable strategies that strengthen the state's life sciences ecosystem.

With more than two decades of experience in strategic engagement, marketing, operations, and industry development, Stacey brings a collaborative, mission-driven approach to leadership that aligns closely with Georgia Life Sciences' vision for the future.

< Older Post